Почетна › Акутна лимфобластна леукемија › Њујорк › New York City
Клинички испитувања за Акутна лимфобластна леукемија во New York City, NY
23 студии за Акутна лимфобластна леукемија бараат учесници на локации во и околу New York City (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Се регрутираФаза 1
- Memorial Sloan Kettering Cancer Center, New York
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
Се регрутираФаза 2
- Memorial Sloan Kettering Cancer Center -- Pediatrics, New York
Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
Се регрутираНабљудувачка студија
- Columbia University Medical Center, New York
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Се регрутираФаза 1/2
- Montefiore Medical Center, New York
Cord Blood Transplant in Adults With Blood Cancers
Се регрутираФаза 2
- Memorial Sloan Kettering Cancer Center, New York
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
Се регрутираФаза 1
- Memorial Sloan Kettering Cancer Center, New York
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Се регрутираФаза 1/2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
Се регрутираФаза 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of CTD402 in T-ALL/LBL Patients
Се регрутираФаза 1/2
- Memorial Sloan Kettering Cancer Center, New York
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Се регрутираФаза 1/2
- Research Site, New York
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Се регрутираНабљудувачка студија
- New York University Langone Medical Center, New York
- New York Presbyterian Hospital at Cornell, New York
- Mount Sinai Medical Center - New York, New York
- и уште 3
A Study of Revumenib and Mezigdomide in People With Leukemia
Се регрутираФаза 1/2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
Се регрутираФаза 1/2
- Memorial Sloan Kettering Cancer Center, New York
European Prospective Investigation Into Childhood Cancer
Се регрутираНабљудувачка студија
- Columbia University Irving Medical Center, New York
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
Се регрутираФаза 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Се регрутираФаза 2
- Memorial Sloan Kettering, New York
Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Се регрутираФаза 2
- Memorial Sloan Kettering Cancer Center, New York
A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)
Се регрутираФаза 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
Се регрутираФаза 1
- Memorial Sloan Kettering Cancer Center, New York
A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
Се регрутира
- Columbia University Medical Center, New York
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Се регрутираФаза 1
- Memorial Sloan Kettering Cancer Center, New York
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Се регрутираФаза 1
- Children's Hospital New York-Presbyterian, New York
- Memorial Sloan Kettering Cancer Center, New York
Испитувања за Акутна лимфобластна леукемија во други градови
- Houston, TX28 студии
- Seattle, WA21 студија
- Baldwin Park, CA21 студија
- Chicago, IL20 студии
- Atlanta, GA19 студии
- Memphis, TN16 студии
- Washington, DC16 студии
- Philadelphia, PA16 студии
- Boston, MA15 студии
- Los Angeles, CA14 студии
- Mountain View, CA13 студии
- Durham, NC13 студии
Други студии во New York City
- Рак на дојка136 студии
- Рак на бели дробови со не-мали клетки121 студија
- Рак (сите типови)109 студии
- Рак на простата103 студии
- Метастатски карцином93 студии
- Колоректален карцином78 студии
- Карцином на јајниците69 студии
- Рак на бели дробови60 студии
- Множен миелом60 студии
- Карцином на панкреасот60 студии
- Рак на ендометриумот52 студии
- Акутна миелоидна леукемија51 студија
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.